In relation to older patients, multiple studies of dopaminergic medication‐related behavioural addictions in Parkinson's disease demonstrate lower dopamine transporter levels in the striatum, highlighting differences in the disorders that are likely related to the relationship with dopaminergic medications or Parkinsonian pathology.61 Here, SLC6A3 is linked to Parkinson disease.